Ventus Therapeutics’ $140 Series C Financing

Laura Testa
Tagged:

Latham & Watkins represented SoftBank Vision Fund 2 in the transaction.Ventus Therapeutics, a biopharmaceutical company utilizing structural biology and computational tools to identify and develop small molecule therapeutics…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

…

This content is for Standard 1 Year members only.
Login Join Now